These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28440609)

  • 1. Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma.
    Tas F; Bilgin E; Erturk K; Duranyildiz D
    Asian Pac J Cancer Prev; 2017 Mar; 18(3):599-601. PubMed ID: 28440609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum claudin-1 levels in melanoma patients.
    Tas F; Bilgin E; Erturk K; Duranyildiz D
    Melanoma Res; 2016 Aug; 26(4):377-81. PubMed ID: 26886788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum caveolin-1 levels in melanoma patients.
    Tas F; Karabulut S; Tilgen Yasasever C; Duranyildiz D
    Int J Dermatol; 2016 May; 55(5):558-62. PubMed ID: 26084616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients.
    Tas F; Karabulut S; Bilgin E; Tastekin D; Duranyildiz D
    Melanoma Res; 2014 Oct; 24(5):475-9. PubMed ID: 24999757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma.
    Tas F; Bilgin E; Karabulut S; Erturk K; Duranyildiz D
    BBA Clin; 2016 Jun; 5():166-9. PubMed ID: 27141440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum transforming growth factor-beta 1 (TGF-β1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma.
    Tas F; Karabulut S; Yasasever CT; Duranyildiz D
    Tumour Biol; 2014 Jul; 35(7):7233-7. PubMed ID: 24771267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer.
    Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.
    Tas F; Bilgin E; Tastekin D; Erturk K; Duranyildiz D
    J Gastrointest Cancer; 2016 Jun; 47(2):182-6. PubMed ID: 27038444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.
    Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
    Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma.
    Lebret T; Watson RW; Molinié V; O'Neill A; Gabriel C; Fitzpatrick JM; Botto H
    Cancer; 2003 Sep; 98(5):970-7. PubMed ID: 12942564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of heat shock protein 90α in malignant melanoma.
    Zhang T; Li Q; Zhang Y; Wang Q; Wang H; Gu K
    Melanoma Res; 2021 Apr; 31(2):152-161. PubMed ID: 33492051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?
    Erturk K; Tastekin D; Bilgin E; Serilmez M; Bozbey HU; Sakar B
    Biomed Pharmacother; 2016 Feb; 77():86-91. PubMed ID: 26796270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
    Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
    Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer.
    Tas F; Bilgin E; Karabulut S; Duranyildiz D
    Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum M30 and M65 levels in melanoma.
    Tas F; Karabulut S; Serilmez M; Yildiz I; Sen F; Ciftci R; Duranyildiz D
    Melanoma Res; 2013 Oct; 23(5):390-5. PubMed ID: 23812330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp90 - a potential prognostic marker in CML.
    Záčková M; Moučková D; Lopotová T; Ondráčková Z; Klamová H; Moravcová J
    Blood Cells Mol Dis; 2013 Mar; 50(3):184-9. PubMed ID: 23190580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
    Schmidt H; Johansen JS; Gehl J; Geertsen PF; Fode K; von der Maase H
    Cancer; 2006 Mar; 106(5):1130-9. PubMed ID: 16456816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma.
    Tas F; Erturk K
    Mol Clin Oncol; 2017 Dec; 7(6):1142-1146. PubMed ID: 29285390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? A retrospective study of 14 patients with malignant melanoma stage IV.
    Doerler M; Hyun J; Venten I; Potthoff A; Bartke U; Serova K; Hoextermann S; Altmeyer P; Brockmeyer NH
    Eur J Med Res; 2007 Oct; 12(10):497-502. PubMed ID: 18024256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer.
    Cercek A; Shia J; Gollub M; Chou JF; Capanu M; Raasch P; Reidy-Lagunes D; Proia DA; Vakiani E; Solit DB; Saltz LB
    Clin Colorectal Cancer; 2014 Dec; 13(4):207-12. PubMed ID: 25444464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.